These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Methodology of superiority vs. equivalence trials and non-inferiority trials. Christensen E J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447 [TBL] [Abstract][Full Text] [Related]
3. The use of putative placebo in active control trials: two applications in a regulatory setting. Durrleman S; Chaikin P Stat Med; 2003 Mar; 22(6):941-52. PubMed ID: 12627411 [TBL] [Abstract][Full Text] [Related]
4. Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective. Rosenblatt M J Bone Miner Res; 2003 Jun; 18(6):1142-5. PubMed ID: 12817772 [TBL] [Abstract][Full Text] [Related]
5. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics. D'Agostino RB; Massaro JM; Sullivan LM Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555 [TBL] [Abstract][Full Text] [Related]
6. Policy developments in regulatory approval. Temple R Stat Med; 2002 Oct; 21(19):2939-48. PubMed ID: 12325110 [TBL] [Abstract][Full Text] [Related]
7. Methodological aspects of superiority, equivalence, and non-inferiority trials. Stefanos R; Graziella D'; Giovanni T Intern Emerg Med; 2020 Sep; 15(6):1085-1091. PubMed ID: 32705494 [TBL] [Abstract][Full Text] [Related]
8. [Statistical notes. From superiority to non-inferiority clinical trials: a leap in the dark?]. Marubini E; Rebora P; Reina G Ital Heart J Suppl; 2004 Sep; 5(9):712-9. PubMed ID: 15568609 [TBL] [Abstract][Full Text] [Related]
9. Evaluating equivalence and noninferiority trials. Dasgupta A; Lawson KA; Wilson JP Am J Health Syst Pharm; 2010 Aug; 67(16):1337-43. PubMed ID: 20689122 [TBL] [Abstract][Full Text] [Related]
11. [Methodological and statistical aspects of equivalence and non inferiority trials]. Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296 [TBL] [Abstract][Full Text] [Related]
12. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications. Khin NA; Chen YF; Yang Y; Yang P; Laughren TP J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123 [TBL] [Abstract][Full Text] [Related]
13. Placebo-free designs for evaluating new mental health treatments: the use of adaptive treatment strategies. Dawson R; Lavori PW Stat Med; 2004 Nov; 23(21):3249-62. PubMed ID: 15490427 [TBL] [Abstract][Full Text] [Related]
14. Non-inferiority versus superiority drug claims: the (not so) subtle distinction. Ganju J; Rom D Trials; 2017 Jun; 18(1):278. PubMed ID: 28619049 [TBL] [Abstract][Full Text] [Related]
15. Asthma management: the challenge of equivalence. Steinijans VW; Neuhäuser M; Hummel T; Leichtl S; Rathgeb F; Keller A Int J Clin Pharmacol Ther; 1998 Mar; 36(3):117-25. PubMed ID: 9562226 [TBL] [Abstract][Full Text] [Related]
17. Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials. Koopmeiners JS; Hobbs BP Stat Methods Med Res; 2018 May; 27(5):1547-1558. PubMed ID: 27587591 [TBL] [Abstract][Full Text] [Related]
18. Issues in the assessment of non-inferiority: perspectives drawn from case studies. Burger HU; Beyer U; Abt M Pharm Stat; 2011; 10(5):433-9. PubMed ID: 21932300 [TBL] [Abstract][Full Text] [Related]
19. Clinical trials: active control vs placebo--what is ethical? Spławiński J; Kuźniar J Sci Eng Ethics; 2004 Jan; 10(1):73-9. PubMed ID: 14986774 [TBL] [Abstract][Full Text] [Related]